Specifically, studies on mitophagy-related proteins, such as those involved in the PINK1/Parkin and BNIP3/NIX pathways, offer potential avenues to modulate mitophagy levels, thereby influencing tumor cell survival and proliferation, and providing new hope for cancer treatment (59, 60). This evidence concerns the gene BNIP3L and neoplasm.